English
简体中文
Total: £ 56.28
Published Date: 2025-06-24 | Pages: 122 | Tables: 128 | Pharma & Healthcare
In 2024, the global market size of PD-1 and PD-L1 Inhibitors was estimated to be worth US$ 56980 million and is forecast to reach approximately US$ 203110 million by 2031 with a CAGR of 20.2% during the forecast period 2025-2031.
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PD-1 and PD-L1 Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1 and PD-L1 Inhibitors.
The PD-1 and PD-L1 Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PD-1 and PD-L1 Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-1 and PD-L1 Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA
Segment by Type
PD-1 Inhibitors
PD-L1 Inhibitors
Segment by Application
Solid Tumors
Blood-related Tumors
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of PD-1 and PD-L1 Inhibitors in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of PD-1 and PD-L1 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PD-1 and PD-L1 Inhibitors sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 PD-1 and PD-L1 Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 Market by Application
1.3.1 Global PD-1 and PD-L1 Inhibitors Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global PD-1 and PD-L1 Inhibitors Market Size Estimates and Forecasts
2.1.1 Global PD-1 and PD-L1 Inhibitors Revenue 2020-2031
2.1.2 Global PD-1 and PD-L1 Inhibitors Sales 2020-2031
2.2 PD-1 and PD-L1 Inhibitors Market Size by Region: 2024 Versus 2031
2.3 PD-1 and PD-L1 Inhibitors Sales by Region (2020-2031)
2.3.1 Global PD-1 and PD-L1 Inhibitors Sales by Region: 2020-2025
2.3.2 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2026-2031)
2.3.3 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2020-2031)
2.4 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Region (2026-2031)
2.4.1 Global PD-1 and PD-L1 Inhibitors Revenue by Region: 2020-2025
2.4.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2026-2031)
2.4.3 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Type (2020-2031)
3.1.1.1 Global PD-1 and PD-L1 Inhibitors Sales Volume by Type (2020-2031)
3.1.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2031)
3.1.2 Global PD-1 and PD-L1 Inhibitors Revenue by Type (2020-2031)
3.1.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Type (2020-2031)
3.1.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2020-2031)
3.1.3 PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global PD-1 and PD-L1 Inhibitors Sales by Application (2020-2031)
3.2.1.1 Global PD-1 and PD-L1 Inhibitors Sales Volume by Application (2020-2031)
3.2.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2031)
3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue by Application (2020-2031)
3.2.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Application (2020-2031)
3.2.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2020-2031)
3.2.3 PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 PD-1 Inhibitors of PD-1 and PD-L1 Inhibitors Revenue Market Share by Application
3.3.2 PD-L1 Inhibitors of PD-1 and PD-L1 Inhibitors Revenue Market Share by Application
4 Global PD-1 and PD-L1 Inhibitors by Manufacturers
4.1 Global Top PD-1 and PD-L1 Inhibitors Manufacturers by Sales (2020-2025)
4.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Manufacturer (2020-2025)
4.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top PD-1 and PD-L1 Inhibitors Manufacturers by Revenue (2020-2025)
4.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Manufacturer (2020-2025)
4.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturer (2020-2025)
4.3 Global PD-1 and PD-L1 Inhibitors Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key PD-1 and PD-L1 Inhibitors Manufacturers Covered: Ranking by Revenue
4.4.2 Global PD-1 and PD-L1 Inhibitors Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global PD-1 and PD-L1 Inhibitors Manufacturing Base Distribution, Product Type
4.5.1 PD-1 and PD-L1 Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
4.5.3 Manufacturers PD-1 and PD-L1 Inhibitors Product Type and Application
4.5.4 PD-1 Inhibitors Market Sales of PD-1 and PD-L1 Inhibitors by Manufacturer
4.5.5 PD-L1 Inhibitors Market Sales of PD-1 and PD-L1 Inhibitors by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck PD-1 and PD-L1 Inhibitors Products Offered
5.1.4 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.1.6 Merck PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.1.7 Merck PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Bristol-Myers Squibb
5.2.1 Bristol-Myers Squibb Company Information
5.2.2 Bristol-Myers Squibb Description, Business Overview
5.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Products Offered
5.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.2.6 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.2.7 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.2.8 Bristol-Myers Squibb Recent Developments
5.3 Roche
5.3.1 Roche Company Information
5.3.2 Roche Description, Business Overview
5.3.3 Roche PD-1 and PD-L1 Inhibitors Products Offered
5.3.4 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Roche PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.3.6 Roche PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.3.7 Roche PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.3.8 Roche Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Company Information
5.4.2 AstraZeneca Description, Business Overview
5.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Products Offered
5.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.4.5 AstraZeneca PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.4.6 AstraZeneca PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.4.7 AstraZeneca PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.4.8 AstraZeneca Recent Developments
5.5 Ono Pharmaceutical
5.5.1 Ono Pharmaceutical Company Information
5.5.2 Ono Pharmaceutical Description, Business Overview
5.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Products Offered
5.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.5.6 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.5.7 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.5.8 Ono Pharmaceutical Recent Developments
5.6 Regeneron
5.6.1 Regeneron Company Information
5.6.2 Regeneron Description, Business Overview
5.6.3 Regeneron PD-1 and PD-L1 Inhibitors Products Offered
5.6.4 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Regeneron PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.6.6 Regeneron PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.6.7 Regeneron PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.6.8 Regeneron Recent Developments
5.7 Innovent
5.7.1 Innovent Company Information
5.7.2 Innovent Description, Business Overview
5.7.3 Innovent PD-1 and PD-L1 Inhibitors Products Offered
5.7.4 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Innovent PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.7.6 Innovent PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.7.7 Innovent PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.7.8 Innovent Recent Developments
5.8 Hengrui Medicine
5.8.1 Hengrui Medicine Company Information
5.8.2 Hengrui Medicine Description, Business Overview
5.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Products Offered
5.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.8.6 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.8.7 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.8.8 Hengrui Medicine Recent Developments
5.9 Junshi Biosciences
5.9.1 Junshi Biosciences Company Information
5.9.2 Junshi Biosciences Description, Business Overview
5.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Products Offered
5.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.9.6 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.9.7 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.9.8 Junshi Biosciences Recent Developments
5.10 Merck KGaA
5.10.1 Merck KGaA Company Information
5.10.2 Merck KGaA Description, Business Overview
5.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Products Offered
5.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Merck KGaA PD-1 and PD-L1 Inhibitors Sales by Product in 2024
5.10.6 Merck KGaA PD-1 and PD-L1 Inhibitors Sales by Application in 2024
5.10.7 Merck KGaA PD-1 and PD-L1 Inhibitors Sales by Geographic Area in 2024
5.10.8 Merck KGaA Recent Developments
6 North America
6.1 North America PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2020-2031
6.2 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
6.2.1 North America PD-1 and PD-L1 Inhibitors Sales by Country (2020-2031)
6.2.2 North America PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2031)
6.3 North America PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
6.4 North America PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2020-2031
7.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Facts & Figures by Region
7.2.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2020-2031)
7.2.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2020-2031)
7.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
7.4 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
8 Europe
8.1 Europe PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2020-2031
8.2 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
8.2.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2020-2031)
8.2.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2031)
8.3 Europe PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
8.4 Europe PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
9 Latin America
9.1 Latin America PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2020-2031
9.2 Latin America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
9.2.1 Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2020-2031)
9.2.2 Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2031)
9.3 Latin America PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
9.4 Latin America PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America PD-1 and PD-L1 Inhibitors Market Size YoY Growth 2020-2031
10.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
10.2.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2020-2031)
10.2.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2031)
10.3 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025)
10.4 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 PD-1 and PD-L1 Inhibitors Supply Chain Analysis
11.2 PD-1 and PD-L1 Inhibitors Key Raw Materials and Upstream Suppliers
11.3 PD-1 and PD-L1 Inhibitors Clients Analysis
11.4 PD-1 and PD-L1 Inhibitors Sales Channel and Sales Model Analysis
11.4.1 PD-1 and PD-L1 Inhibitors Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 PD-1 and PD-L1 Inhibitors Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 PD-1 and PD-L1 Inhibitors Distributors
12 PD-1 and PD-L1 Inhibitors Market Dynamics
12.1 PD-1 and PD-L1 Inhibitors Industry Trends
12.2 PD-1 and PD-L1 Inhibitors Market Drivers
12.3 PD-1 and PD-L1 Inhibitors Market Challenges
12.4 PD-1 and PD-L1 Inhibitors Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global PD-1 and PD-L1 Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global PD-1 and PD-L1 Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global PD-1 and PD-L1 Inhibitors Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global PD-1 and PD-L1 Inhibitors Sales by Region (2020-2025) & (L)
Table 5. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2026-2031) & (L)
Table 6. Global PD-1 and PD-L1 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global PD-1 and PD-L1 Inhibitors Sales Volume by Type (2020-2025) & (L)
Table 9. Global PD-1 and PD-L1 Inhibitors Sales Volume by Type (2026-2031) & (L)
Table 10. Global PD-1 and PD-L1 Inhibitors Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global PD-1 and PD-L1 Inhibitors Sales Volume by Application (2020-2025) & (L)
Table 13. Global PD-1 and PD-L1 Inhibitors Sales Volume by Application (2026-2031) & (L)
Table 14. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global PD-1 and PD-L1 Inhibitors Sales by Manufacturer (2020-2025) & (L)
Table 17. Global PD-1 and PD-L1 Inhibitors Sales Share by Manufacturer (2020-2025)
Table 18. PD-1 and PD-L1 Inhibitors Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers PD-1 and PD-L1 Inhibitors Price (2020-2025) & (USD/ml)
Table 21. Ranking of Global Top PD-1 and PD-L1 Inhibitors Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2024)
Table 24. PD-1 and PD-L1 Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
Table 26. Manufacturers PD-1 and PD-L1 Inhibitors Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Merck Company Information
Table 29. Merck Description and Business Overview
Table 30. Merck PD-1 and PD-L1 Inhibitors Product
Table 31. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 32. Merck Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 33. Merck Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 34. Merck Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 35. Merck Recent Developments
Table 36. Bristol-Myers Squibb Company Information
Table 37. Bristol-Myers Squibb Description and Business Overview
Table 38. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product
Table 39. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 40. Bristol-Myers Squibb Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 41. Bristol-Myers Squibb Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 42. Bristol-Myers Squibb Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 43. Bristol-Myers Squibb Recent Developments
Table 44. Roche Company Information
Table 45. Roche Description and Business Overview
Table 46. Roche PD-1 and PD-L1 Inhibitors Product
Table 47. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 48. Roche Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 49. Roche Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 50. Roche Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 51. Roche Recent Developments
Table 52. AstraZeneca Company Information
Table 53. AstraZeneca Description and Business Overview
Table 54. AstraZeneca PD-1 and PD-L1 Inhibitors Product
Table 55. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 56. AstraZeneca Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 57. AstraZeneca Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 58. AstraZeneca Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 59. AstraZeneca Recent Developments
Table 60. Ono Pharmaceutical Company Information
Table 61. Ono Pharmaceutical Description and Business Overview
Table 62. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product
Table 63. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 64. Ono Pharmaceutical Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 65. Ono Pharmaceutical Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 66. Ono Pharmaceutical Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 67. Ono Pharmaceutical Recent Developments
Table 68. Regeneron Company Information
Table 69. Regeneron Description and Business Overview
Table 70. Regeneron PD-1 and PD-L1 Inhibitors Product
Table 71. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 72. Regeneron Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 73. Regeneron Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 74. Regeneron Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 75. Regeneron Recent Developments
Table 76. Innovent Company Information
Table 77. Innovent Description and Business Overview
Table 78. Innovent PD-1 and PD-L1 Inhibitors Product
Table 79. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 80. Innovent Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 81. Innovent Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 82. Innovent Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 83. Innovent Recent Developments
Table 84. Hengrui Medicine Company Information
Table 85. Hengrui Medicine Description and Business Overview
Table 86. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product
Table 87. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 88. Hengrui Medicine Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 89. Hengrui Medicine Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 90. Hengrui Medicine Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 91. Hengrui Medicine Recent Developments
Table 92. Junshi Biosciences Company Information
Table 93. Junshi Biosciences Description and Business Overview
Table 94. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product
Table 95. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 96. Junshi Biosciences Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 97. Junshi Biosciences Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 98. Junshi Biosciences Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 99. Junshi Biosciences Recent Developments
Table 100. Merck KGaA Company Information
Table 101. Merck KGaA Description and Business Overview
Table 102. Merck KGaA PD-1 and PD-L1 Inhibitors Product
Table 103. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2020-2025)
Table 104. Merck KGaA Sales Proportion of PD-1 and PD-L1 Inhibitors by Product in 2024
Table 105. Merck KGaA Sales Proportion of PD-1 and PD-L1 Inhibitors by Application in 2024
Table 106. Merck KGaA Sales Proportion of PD-1 and PD-L1 Inhibitors by Geographic Area in 2024
Table 107. Merck KGaA Recent Developments
Table 108. North America PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 109. North America PD-1 and PD-L1 Inhibitors Sales by Country (2026-2031) & (L)
Table 110. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 111. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 112. North America PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025) & (L)
Table 113. North America PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 114. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2020-2025) & (L)
Table 115. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2026-2031) & (L)
Table 116. Asia-Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 117. Asia-Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 118. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025) & (L)
Table 119. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 120. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 121. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2026-2031) & (L)
Table 122. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 123. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 124. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025) & (L)
Table 125. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 126. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 127. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2026-2031) & (L)
Table 128. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 129. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 130. Latin America PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025) & (L)
Table 131. Latin America PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 132. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2020-2025) & (L)
Table 133. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2026-2031) & (L)
Table 134. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 135. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 136. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Type (2020-2025) & (L)
Table 137. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Application (2020-2025) & (L)
Table 138. PD-1 and PD-L1 Inhibitors Key Raw Materials, Industry Status and Trend
Table 139. PD-1 and PD-L1 Inhibitors Key Raw Materials and Upstream Suppliers
Table 140. PD-1 and PD-L1 Inhibitors Clients Status and Trend
Table 141. PD-1 and PD-L1 Inhibitors Typical Clients
Table 142. PD-1 and PD-L1 Inhibitors Distributors
Table 143. PD-1 and PD-L1 Inhibitors Market Trends
Table 144. PD-1 and PD-L1 Inhibitors Market Drivers
Table 145. PD-1 and PD-L1 Inhibitors Market Challenges
Table 146. PD-1 and PD-L1 Inhibitors Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. PD-1 and PD-L1 Inhibitors Product Picture
Figure 2. Global PD-1 and PD-L1 Inhibitors Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2024 & 2031
Figure 4. PD-1 Inhibitors Product Picture
Figure 5. PD-L1 Inhibitors Product Picture
Figure 6. Global PD-1 and PD-L1 Inhibitors Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2024 & 2031
Figure 8. Solid Tumors
Figure 9. Blood-related Tumors
Figure 10. PD-1 and PD-L1 Inhibitors Report Years Considered
Figure 11. Global PD-1 and PD-L1 Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global PD-1 and PD-L1 Inhibitors Market Size 2020-2031 (US$ Million)
Figure 13. Global PD-1 and PD-L1 Inhibitors Sales 2020-2031 (L)
Figure 14. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 16. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Type (2020-2031)
Figure 18. PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) by Type (2020-2025) & (USD/ml)
Figure 19. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Application (2020-2031)
Figure 21. PD-1 and PD-L1 Inhibitors Average Selling Price (ASP) by Application (2020-2025) & (USD/ml)
Figure 22. PD-1 Inhibitors of PD-1 and PD-L1 Inhibitors Revenue Market Share by Application, 2024 VS 2031
Figure 23. PD-L1 Inhibitors of PD-1 and PD-L1 Inhibitors Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global PD-1 and PD-L1 Inhibitors Sales Share by Manufacturer in 2024
Figure 25. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. PD-1 Inhibitors Market Sales Proportion by Manufacturer in 2024
Figure 27. PD-L1 Inhibitors Market Sales Proportion by Manufacturer in 2024
Figure 28. North America PD-1 and PD-L1 Inhibitors Revenue 2020-2031 (US$ Million)
Figure 29. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2025)
Figure 30. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific PD-1 and PD-L1 Inhibitors Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 36. Europe PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2020-2031)
Figure 38. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 39. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2025)
Figure 40. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 41. Latin America PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2020-2031)
Figure 43. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2025)
Figure 44. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2025)
Figure 45. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2020-2025)
Figure 51. PD-1 and PD-L1 Inhibitors Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of PD-1 and PD-L1 Inhibitors Raw Materials by Region in 2024
Figure 53. PD-1 and PD-L1 Inhibitors Distribution Channels
Figure 54. Global PD-1 and PD-L1 Inhibitors Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global PD-1 and PD-L1 Inhibitors Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
